Delivery Order SPE2DR25D3501-SPE2DR26FL9FQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $5,646.47. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $2,524.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger pharmaceutical supply framework. The order is scheduled for completion by December 1, 2025, and will be fulfilled from AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count) with a ceiling value of $20,903.91. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains operations as one of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Myrbetriq ER 25 mg tablets (30-count) valued at $3,773.91. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $3,853.29 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for Myrbetriq ER 50 mg tablets (90-count supply). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and represents a child delivery order under a larger contract vehicle. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $50,783.29 on October 31, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by November 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,881.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on November 5, 2025, with completion required by November 6, 2025. This non-set-aside delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's broader relationship with the federal government, fulfilling medical procurement needs for military and veteran healthcare systems. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging) valued at $24,907.29. This firm fixed-price delivery order, with completion targeted for November 7, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $4,335.64. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by December 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $18,882.28 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 21, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9FQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (30-count packages) with a contract value of $9,750.53. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date of November 25, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military and veteran healthcare systems. The DLA Troop Support Medical contract vehicle enables the company to fulfill pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally, demonstrating the company's established capability to meet complex federal medical procurement requirements through competitive delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 11/23/25 |